132 related articles for article (PubMed ID: 15968288)
1. Bone mineral density in children with thalassaemia major: determining factors and effects of bone marrow transplantation.
Leung TF; Hung EC; Lam CW; Li CK; Chu Y; Chik KW; Shing MM; Lee V; Yuen PM
Bone Marrow Transplant; 2005 Aug; 36(4):331-6. PubMed ID: 15968288
[TBL] [Abstract][Full Text] [Related]
2. Bone mineral metabolism in adults with beta-thalassaemia major and intermedia.
Dresner Pollack R; Rachmilewitz E; Blumenfeld A; Idelson M; Goldfarb AW
Br J Haematol; 2000 Dec; 111(3):902-7. PubMed ID: 11122154
[TBL] [Abstract][Full Text] [Related]
3. Bone mineral density in pediatric transplant recipients.
Daniels MW; Wilson DM; Paguntalan HG; Hoffman AR; Bachrach LK
Transplantation; 2003 Aug; 76(4):673-8. PubMed ID: 12973107
[TBL] [Abstract][Full Text] [Related]
4. Bone mineral density in postmenarchal adolescent girls in the United States: associated biopsychosocial variables and bone turnover markers.
Harel Z; Gold M; Cromer B; Bruner A; Stager M; Bachrach L; Wolter K; Reid C; Hertweck P; Nelson A; Nelson D; Coupey S; Johnson C; Burkman R; Bone H
J Adolesc Health; 2007 Jan; 40(1):44-53. PubMed ID: 17185205
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, placebo-controlled trial of intravenous zoledronic acid in the treatment of thalassemia-associated osteopenia.
Gilfillan CP; Strauss BJ; Rodda CP; Bowden DK; Kean AM; Obaid M; Crawford BA
Calcif Tissue Int; 2006 Sep; 79(3):138-44. PubMed ID: 16969592
[TBL] [Abstract][Full Text] [Related]
6. Gender differences in the prevalence and severity of bone disease in thalassaemia.
Kyriakou A; Savva SC; Savvides I; Pangalou E; Ioannou YS; Christou S; Skordis N
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():116-22. PubMed ID: 19337164
[TBL] [Abstract][Full Text] [Related]
7. Effect of bisphosphonate treatment on bone mineral density in patients with thalassaemia major.
Skordis N; Ioannou YS; Kyriakou A; Savva SC; Efstathiou E; Savvides I; Christou S
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():144-8. PubMed ID: 19337169
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing changes in bone mineral density in patients with anorexia nervosa-related osteoporosis: the effect of hormone replacement therapy.
Legroux-Gerot I; Vignau J; Collier F; Cortet B
Calcif Tissue Int; 2008 Nov; 83(5):315-23. PubMed ID: 18836675
[TBL] [Abstract][Full Text] [Related]
9. Marked increases in bone mineral density and biochemical markers of bone turnover in patients with anorexia nervosa gaining weight.
Viapiana O; Gatti D; Dalle Grave R; Todesco T; Rossini M; Braga V; Idolazzi L; Fracassi E; Adami S
Bone; 2007 Apr; 40(4):1073-7. PubMed ID: 17240212
[TBL] [Abstract][Full Text] [Related]
10. Bone mineral density in beta-thalassemia major and intermedia.
Karimi M; Ghiam AF; Hashemi A; Alinejad S; Soweid M; Kashef S
Indian Pediatr; 2007 Jan; 44(1):29-32. PubMed ID: 17277428
[TBL] [Abstract][Full Text] [Related]
11. Effects of thalassemia major on bone mineral density in late adolescence.
Benigno V; Bertelloni S; Baroncelli GI; Bertacca L; Di Peri S; Cuccia L; Borsellino Z; Maggio MC
J Pediatr Endocrinol Metab; 2003 Mar; 16 Suppl 2():337-42. PubMed ID: 12729413
[TBL] [Abstract][Full Text] [Related]
12. Elevation of intact parathyroid hormone level is a risk factor for low bone mineral density in pretransplant patients with liver diseases.
Bai XL; Liang TB; Wu LH; Li DL; Geng L; Wang WL; Shen Y; Zhang M; Zheng SS
Transplant Proc; 2007 Dec; 39(10):3182-5. PubMed ID: 18089348
[TBL] [Abstract][Full Text] [Related]
13. Biochemical markers of bone turnover and bone mineral density in patients with beta-thalassaemia major.
Eren E; Yilmaz N
Int J Clin Pract; 2005 Jan; 59(1):46-51. PubMed ID: 15707464
[TBL] [Abstract][Full Text] [Related]
14. The "lively" cytokines network in beta-Thalassemia Major-related osteoporosis.
Morabito N; Russo GT; Gaudio A; Lasco A; Catalano A; Morini E; Franchina F; Maisano D; La Rosa M; Plota M; Crifò A; Meo A; Frisina N
Bone; 2007 Jun; 40(6):1588-94. PubMed ID: 17412659
[TBL] [Abstract][Full Text] [Related]
15. Peripheral and central measurements of bone mineral density are equally strongly associated with clinical risk factors for osteoporosis.
Patel R; Blake GM; Fogelman I
Calcif Tissue Int; 2007 Feb; 80(2):89-96. PubMed ID: 17308990
[TBL] [Abstract][Full Text] [Related]
16. Bone mineral density in patients undergoing bone marrow transplantation for myeloid malignancies.
Bhatia S; Ramsay NK; Weisdorf D; Griffiths H; Robison LL
Bone Marrow Transplant; 1998 Jul; 22(1):87-90. PubMed ID: 9678801
[TBL] [Abstract][Full Text] [Related]
17. Relationship between BMD, dental panoramic radiographic findings and biochemical markers of bone turnover in diagnosis of osteoporosis.
Vlasiadis KZ; Damilakis J; Velegrakis GA; Skouteris CA; Fragouli I; Goumenou A; Matalliotakis J; Koumantakis EE
Maturitas; 2008 Mar; 59(3):226-33. PubMed ID: 18342460
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience.
Sethi BK; Chadha M; Modi KD; Kumar KM; Mehrotra R; Sriram U
J Assoc Physicians India; 2008 Jun; 56():418-24. PubMed ID: 18822620
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects of pamidronate in thalassemic patients with severe bone mineral density deficits.
Leung TF; Chu Y; Lee V; Cheng FW; Leung WK; Shing MM; Li CK
Hemoglobin; 2009; 33(5):361-9. PubMed ID: 19814683
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and predictors of osteopenia and osteoporosis in adults with Type 1 diabetes.
Hamilton EJ; Rakic V; Davis WA; Chubb SA; Kamber N; Prince RL; Davis TM
Diabet Med; 2009 Jan; 26(1):45-52. PubMed ID: 19125760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
